Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model

American Journal of Pathology

Volumn 178, Issue 2, 2011, Pages 803-816

  Ando, Kunie ^a   Leroy, Karelle ^a   Héraud, Céline ^a   Yilmaz, Zehra ^a   Authelet, Michèle ^a   Suain, Valèrie ^a   De Decker, Robert ^a   Brion, Jean Pierre ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL COUNT; CELL INCLUSION; DISEASE SEVERITY; HIPPOCAMPUS; MOTOR DYSFUNCTION; MOUSE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SPINAL CORD; WILD TYPE; WORKING MEMORY;

EID: 79951819429     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.10.034     Document Type: Article

References (79)

1. Selkoe DJ: The origins of Alzheimer disease - A is for amyloid. JAMA 2000, 283:1615-1617
2. Ballatore C, Lee VMY, Trojanowski JQ: Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 2007, 8:663-672 (Pubitemid 47283144)
3. van Swieten J, Spillantini MG: Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol 2007, 17:63-73
4. Denk F, Wade-Martins R: Knock-out and transgenic mouse models of tauopathies. Neurobiol Aging 2009, 30:1-13
5. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E: Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 2001, 293:1487-1491 (Pubitemid 32801551)
6. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM: Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421 (Pubitemid 36937044)
7. Pérez M, Ribe E, Rubio A, Lim F, Morán MA, Ramos PG, Ferrer I, Isla MT, Avila J: Characterization of a double (amyloid precursor proteintau) transgenic: tau phosphorylation and aggregation. Neuroscience 2005, 130:339-347 (Pubitemid 40125472)
8. Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F: Amyloid activates GSK-3 beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol 2008, 172:786-798 (Pubitemid 351354550)
9. Götz J, Ittner LM: Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 2008, 9:532-544 (Pubitemid 351873467)
10. Brion JP, Tremp G, Octave JN: Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer disease. Am J Pathol 1999, 154:255-270
11. Götz J, Probst A, Spillantini MG, Schäfer T, Jakes R, Bürki K, Goedert M: Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J 1995, 14:1304-1313
12. Higuchi M, Ishihara T, Zhang B, Hong M, Andreadis A, Trojanowski JQ, Lee VMY: Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Neuron 2002, 35:433-446 (Pubitemid 34879944)
13. Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski JQ, Lee VMY: Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 1999, 24:751-762
14. Ishihara T, Zhang B, Higuchi M, Yoshiyama Y, Trojanowski JQ, Lee VMY: Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am J Pathol 2001, 158:555-562 (Pubitemid 32158616)
15. Probst A, Götz J, Wiederhold KH, Tolnay M, Mistl C, Jaton AL, Hong M, Ishihara T, Lee VM, Trojanowski JQ, Jakes R, Crowther RA, Spillantini MG, Bürki K, Goedert M: Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol 2000, 99:469-481 (Pubitemid 30201307)
16. Duff K, Knight H, Refolo LM, Sanders S, Yu X, Picciano M, Malester B, Hutton M, Adamson J, Goedert M, Burki K, Davies P: Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiol Dis 2000, 7:87-98 (Pubitemid 30241205)
17. Andorfer C, Kress Y, Espinoza M, De Silva R, Tucker KL, Barde YA, Duff K, Davies P: Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J Neurochem 2003, 86:582-590 (Pubitemid 36897439)
18. Andorfer C, Acker CM, Kress Y, Hof PR, Duff K, Davies P: Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J Neurosci 2005, 25:5446-5454 (Pubitemid 40770926)
19. Terwel D, Lasrado R, Snauwaert J, Vandeweert E, Van Haesendonck C, Borghgraef P, Van Leuven F: Changed conformation of mutant tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of tau-4R/2N transgenic mice. J Biol Chem 2005, 280:3963-3973 (Pubitemid 40227485)
20. Schindowski K, Bretteville A, Leroy K, Begard S, Brion JP, Hamdane M, Buée L: Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 2006, 169:599-616 (Pubitemid 44156317)
21. Leroy K, Bretteville A, Schindowski K, Gilissen E, Authelet M, De Decker R, Yilmaz Z, Buee L, Brion JP: Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. Am J Pathol 2007, 171:976-992 (Pubitemid 47440995)
22. Tucker KL, Meyer M, Barde YA: Neurotrophins are required for nerve growth during development. Nat Neurosci 2001, 4:29-37
23. Boutajangout A, Authelet M, Blanchard V, Touchet N, Tremp G, Pradier L, Brion JP: Cytoskeletal abnormalities in mice transgenic for human tau and familial Alzheimer's disease mutants of APP and presenilin-1, Neurobiology of disease 2004, 15:47-60 (Pubitemid 38134380)
24. Leroy K, Bretteville A, Schindowski K, Gilissen E, Authelet M, De Decker R, Yilmaz Z, Buée L, Brion JP: Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice. Am J Pathol 2007, 171:976-992 (Pubitemid 47440995)
25. Leroy K, Ando K, Heraud C, Yilmaz Z, Authelet M, Boeynaems JM, Buee L, De Decker R, Brion JP: Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology. J Alzheimers Dis 2010, 19:705-719
26. Holcomb LA, Gordon MN, Jantzen P, Hsiao K, Duff K, Morgan D: Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet 1999, 29:177-185 (Pubitemid 29500635)
27. Brion JP, Hanger DP, Bruce MT, Couck AM, Flament-Durand J, Anderton BH: Tau in Alzheimer neurofibrillary tangles: N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site. Biochem J 1991, 273:127-133
28. Hanger DP, Gibb GM, de Silva R, Boutajangout A, Brion JP, Revesz T, Lees AJ, Anderton BH: The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies. FEBS Lett 2002, 531:538-542 (Pubitemid 35336082)
29. Sennvik K, Boekhoorn K, Lasrado R, Terwel D, Verhaeghe S, Korr H, Schmitz C, Tomiyama T, Mori H, Krugers H, Joels M, Ramakers GJA, Lucassen PJ, Van Leuven F: Tau-4R suppresses proliferation and promotes neuronal differentiation in the hippocampus of tau knockin/ knockout mice. FASEB J 2007, 21:2149-2161 (Pubitemid 47026450)
30. Davis DR, Brion JP, Couck AM, Gallo JM, Hanger DP, Ladhani K, Lewis C, Miller CCJ, Rupniak T, Smith C, Anderton BH: The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and beta-amyloid in primary rat cortical neuronal cultures. Biochem J 1995, 309:941-949
31. Brion JP, Couck AM, Robertson J, Loviny TLF, Anderton BH: Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in PHF-tau in Alzheimer's disease. J Neurochem 1993, 60:1372-1382 (Pubitemid 23088312)
32. Goedert M, Jakes R, Vanmechelen E: Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995, 189:167-170
33. Goedert M, Jakes R, Crowther RA, Cohen P, Vanmechelen E, Vandermeeren M, Cras P: Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. Biochem J 1994, 301:871-877 (Pubitemid 24239324)
34. Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM: Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 1994, 39:669-673
35. Jicha GA, Bowser R, Kazam IG, Davies P: Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 1997, 48:128-132 (Pubitemid 27181338)
36. Planel E, Krishnamurthy P, Miyasaka T, Liu L, Herman M, Kumar A, Bretteville A, Figueroa HY, Yu WH, Whittington RA, Davies P, Takashima A, Nixon RA, Duff KE: Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo. J Neurosci 2008, 28:12798-12807
37. Brion JP, Hanger DP, Couck AM, Anderton BH: A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities. Biochem J 1991, 279:831-836
38. West MJ, Slomianka L, Gundersen HJ: Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991, 231:482-497
39. Williams RW, Rakic P: Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material [Erratum appeared in J Comp Neurol 1989, 281:335]. J Comp Neurol 1988, 278:344-352 (Pubitemid 19004342)
40. Schmitz C, Hof PR: Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach. J Chem Neuroanat 2000, 20:93-114
41. Schmitz C, Hof PR: Design-based stereology in neuroscience. Neuroscience 2005, 130:813-831 (Pubitemid 40094616)
42. Slomianka L, West MJ: Estimators of the precision of stereological estimates: an example based on the CA1 pyramidal cell layer of rats. Neuroscience 2005, 136:757-767 (Pubitemid 41774722)
43. Cavalieri B: Geometria Indivisibilibus Continuorum [Geometry of Indivisible Continua]. Latin. Bononia [Bologna]: Typis Clementis Ferronij, 1635.
44. Translated as Geometria Degli Indivisibili [Geometry of Indivisibles]. Italian. Edited by L Lombardo-Radice. Turin, Italy: Unione Tipografico-Editrice Torinese, 1966
45. Paxinos G, Franklin KBJ:The mouse brain in stereotaxic coordinates, 2nd ed. London: Academic Press, 2001
46. Goñi-Oliver P, Lucas JJ, Avila J, Hernández F: N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation. J Biol Chem 2007, 282:22406-22413
47. Greenberg SG, Davies P: A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 1990, 87:5827-5831
48. Sahara N, Maeda S, Yoshiike Y, Mizoroki T, Yamashita S, Murayama M, Park JM, Saito Y, Murayama S, Takashima A: Molecular chaperone- mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brain. J Neurosci Res 2007, 85:3098-3108 (Pubitemid 350057365)
49. Katsuno T, Morishima-Kawashima M, Saito Y, Yamanouchi H, Ishiura S, Murayama S, Ihara Y: Independent accumulations of tau and amyloid beta-protein in the human entorhinal cortex. Neurology 2005, 64:687-692 (Pubitemid 40261899)
50. Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, Yoshida H, Holzer M, Craxton M, Emson PC, Atzori C, Migheli A, Crowther RA, Ghetti B, Spillantini MG, Goedert M: Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 2002, 22:9340-9351 (Pubitemid 35356177)
51. Sahara N, Lewis J, DeTure M, McGowan E, Dickson DW, Hutton M, Yen SH: Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility. J Neurochem 2002, 83:1498-1508 (Pubitemid 35477488)
52. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, Jucker M, Goedert M, Tolnay M: Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 2009, 11:909-913
53. Kampers T, Pangalos M, Geerts H, Wiech H, Mandelkow E: Assembly of paired helical filaments from mouse tau: implications for the neurofibrillary pathology in transgenic mouse models for Alzheimer's disease. FEBS Lett 1999, 451:39-44 (Pubitemid 29236169)
54. Chohan MO, Haque N, Alonso A, El-Akkad E, Grundke-Iqbal I, Grover A, Iqbal K: Hyperphosphorylation-induced self assembly of murine tau: a comparison with human tau. J Neural Transm 2005, 112:1035-1047 (Pubitemid 40991519)
55. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH: Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 2003, 40:471-483 (Pubitemid 37494698)
56. Liou YC, Sun A, Ryo A, Zhou XZ, Yu ZX, Huang HK, Uchida T, Bronson R, Bing G, Li X, Hunter T, Lu KP: Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 2003, 424:556-561 (Pubitemid 36975777)
57. Mocanu MM, Nissen A, Eckermann K, Khlistunova I, Biernat J, Drexler D, Petrova O, Schönig K, Bujard H, Mandelkow E, Zhou L, Rune G, Mandelkow EM: The potential for beta-structure in the repeat domain of Tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J Neurosci 2008, 28:737-748 (Pubitemid 351159036)
58. Adams SJ, Crook RJ, DeTure M, Randle SJ, Innes AE, Yu XZ, Lin WL, Dugger BN, McBride M, Hutton M, Dickson DW, McGowan E: Overexpression of wild-type murine tau results in progressive tauopathy and neurodegeneration. Am J Pathol 2009, 175:1598-1609
59. Leroy K, Yilmaz Z, Brion JP: Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurons at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 2007, 33:43-55 (Pubitemid 46090309)
60. Pei JJ, Tanaka T, Tung YC, Braak E, Iqbal K, Grundke-Iqbal I: Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 1997, 56:70-78 (Pubitemid 127470328)
61. Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, Lewis J, Hutton M, Dickson DW, Yen SH: Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. Am J Pathol 2003, 163:1057-1067 (Pubitemid 37040141)
62. Lesort M, Jope RS, Johnson GV: Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J Neurochem 1999, 72:576-584 (Pubitemid 29055219)
63. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wölfing H, Chieng BC, Christie MJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E, Götz J: Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010, 142:387-397
64. Adams SJ, DeTure MA, McBride M, Dickson DW, Petrucelli L: Three repeat isoforms of tau inhibit assembly of four repeat tau filaments. PLoS One 2010, 5:e10810
65. Greenwood JA, Scott CW, Spreen RC, Caputo CB, Johnson GVW: Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert. Identification of threonine 39 as the primary phosphate acceptor, J Biol Chem 1994, 269:4373-4380
66. Hanger DP, Byers HL, Wray S, Leung KY, Saxton MJ, Seereeram A, Reynolds CH, Ward MA, Anderton BH: Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J Biol Chem 2007, 282:23645-23654 (Pubitemid 47311907)
67. Saitoh T, Iimoto D: Aberrant protein phosphorylation and cytoarchitecture in Alzheimer's disease. Prog Clin Biol Res 1989, 317:769-780
68. Lee G, Thangavel R, Sharma VM, Litersky JM, Bhaskar K, Fang SM, Do LH, Andreadis A, Van Hoesen G, Ksiezak-Reding H: Phosphorylation of tau by fyn: implications for Alzheimer's disease. J Neurosci 2004, 24:2304-2312 (Pubitemid 38314562)
69. Feijoo C, Campbell DG, Jakes R, Goedert M, Cuenda A: Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38 delta at Thr50 promotes microtubule assembly. J Cell Sci 2005, 118:397-408 (Pubitemid 40277351)
70. Rosenberg KJ, Ross JL, Feinstein HE, Feinstein SC, Israelachvili J: Complementary dimerization of microtubule-associated tau protein: implications for microtubule bundling and tau-mediated pathogenesis. Proc Natl Acad Sci USA 2008, 105:7445-7450 (Pubitemid 351830037)
71. Mandelkow EM, Schweers O, Drewes G, Biernat J, Gustke N, Trinczek B, Mandelkow E: Structure, microtubule interactions, and phosphorylation of tau protein. Ann N Y Acad Sci 1996, 777:96-106 (Pubitemid 26149176)
72. Carmel G, Mager EM, Binder LI, Kuret J: The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 1996, 271:32789-32795 (Pubitemid 27008707)
73. Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, Berry RW: Tau, tangles, and Alzheimer's disease. Biochim Biophys Acta 2005, 1739:216-223 (Pubitemid 40018540)
74. Weaver CL, Espinoza M, Kress Y, Davies P: Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol Aging 2000, 21:719-727
75. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL: Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA 2003, 100:10032-10037 (Pubitemid 37087063)
76. Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW: Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 2004, 114:121-130 (Pubitemid 39071651)
77. Delobel P, Lavenir I, Fraser G, Ingram E, Holzer M, Ghetti B, Spillantini MG, Crowther RA, Goedert M: Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy. Am J Pathol 2008, 172:123-131 (Pubitemid 351186374)
78. Pacheco CD, Elrick MJ, Lieberman AP: Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis. Hum Mol Genet 2009, 18:956-965
79. Cripps D, Thomas SN, Jeng Y, Yang F, Davies P, Yang AJ: Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-tau is polyubiquitinated through Lys-48. Lys-11, and Lys-6 ubiquitin conjugation. J Biol Chem 2006, 281:10825-10838 (Pubitemid 43855505)